BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7436574)

  • 1. Circulating and intra-articular immune complexes in rheumatoid arthritis: a comparative study of the C1q binding and monoclonal rheumatoid factor assays.
    Roberts-Thomson PJ; Neoh SH; Bradley J; Milazzo SC
    Ann Rheum Dis; 1980 Oct; 39(5):438-44. PubMed ID: 7436574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.
    Halla JT; Volanakis JE; Schrohenloher RE
    Arthritis Rheum; 1979 May; 22(5):440-8. PubMed ID: 444313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
    Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
    Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
    Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
    J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid factor isotypes and circulating immune complexes in rheumatoid arthritis.
    Zlabinger GJ; Haberhauer G; Dax K; Menzel EJ; Bröll H
    Clin Exp Rheumatol; 1990; 8(2):113-9. PubMed ID: 2338008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
    Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
    Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
    Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
    Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
    Niven IP; Whaley K
    Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased C1q binding immune complexes in Felty's syndrome: comparison with uncomplicated rheumatoid arthritis.
    Hurd ER; Chubick A; Jasin HE; Ziff M
    Arthritis Rheum; 1979 Jul; 22(7):697-702. PubMed ID: 454498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three immunoassays for immune complexes in rheumatoid arthritis.
    Gupta RC; McDuffie FC; Huston KA; Tappeiner G; Meurer M; Jordon RE; Luthra HS; Hunder GG; Ilstrup D
    Arthritis Rheum; 1979 May; 22(5):433-9. PubMed ID: 87203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation and evaluation of low molecular weight IgM in rheumatoid arthritis.
    Roberts-Thomson PJ; Neoh SH; Bradley J
    Ann Rheum Dis; 1980 Aug; 39(4):349-53. PubMed ID: 6893651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes and rheumatoid factors in canine arthritides.
    Carter SD; Bell SC; Bari AS; Bennett D
    Ann Rheum Dis; 1989 Dec; 48(12):986-91. PubMed ID: 2619359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune complexes in the pathogenesis of rheumatoid arthritis].
    Lavrova TR
    Ter Arkh; 1978; 50(10):125-31. PubMed ID: 81534
    [No Abstract]   [Full Text] [Related]  

  • 18. Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients.
    Sawada T; Kanzaki T; Hashimoto S; Suzuki A; Yamada R; Odawara M; Yamamoto K
    Clin Exp Rheumatol; 2009; 27(6):989-92. PubMed ID: 20149318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
    Menzel J; Steffen C
    Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
    Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
    Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.